Director at Helios (NASDAQ: HLIO) exercises RSUs into 1,177 common shares

Rhea-AI Filing Summary

HELIOS TECHNOLOGIES, INC. director Laura D. Brown exercised previously granted restricted stock units that converted into 1,177 shares of Common Stock on March 13, 2026. The units carried no exercise price, and the associated Common Stock entry reflects a price of $64.17 per share for the converted shares. Following this routine equity compensation transaction, Brown directly holds 17,226 shares of Helios common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brown Laura D

(Last) (First) (Middle)

C/O HELIOS TECHNOLOGIES, INC.

7456 16TH ST E

(Street)

SARASOTA FL 34243

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HELIOS TECHNOLOGIES, INC. [ HLIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		M		1,177	A	$64.17	17,226	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/13/2026		M			1,177	(1)	(1)	Common Stock	1,177	$0	0	D

Explanation of Responses:

1. Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

	/s/ Marc Greenberg, Attorney-in-Fact for Laura D. Brown	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HELIOS TECHNOLOGIES (HLIO) report for Laura D. Brown?

HELIOS TECHNOLOGIES reported that director Laura D. Brown exercised restricted stock units that converted into 1,177 shares of Common Stock. This was recorded as a derivative exercise and related common stock acquisition on March 13, 2026.

How many HELIOS TECHNOLOGIES (HLIO) shares does Laura D. Brown hold after this Form 4?

After the reported transaction, director Laura D. Brown directly holds 17,226 shares of HELIOS TECHNOLOGIES Common Stock. This reflects the addition of 1,177 shares from exercising restricted stock units on March 13, 2026.

Did the HELIOS TECHNOLOGIES (HLIO) Form 4 show a stock sale by Laura D. Brown?

No, the Form 4 shows no stock sales by Laura D. Brown. It reports an exercise of restricted stock units into 1,177 shares of Common Stock, with no corresponding disposition or open-market sale on that date.

What does the $64.17 price mean in the HELIOS TECHNOLOGIES (HLIO) Form 4 entry?

The Form 4 lists a $64.17 per share price for the 1,177 Common Stock shares acquired upon RSU conversion. The restricted stock units themselves had an exercise price of $0, consistent with typical equity compensation arrangements upon vesting.

Were any restricted stock units remaining after Laura D. Brown’s HELIOS TECHNOLOGIES (HLIO) transaction?

The filing shows the Restricted Stock Units position at zero shares following the transaction, indicating that 1,177 RSUs were fully converted into an equal number of Common Stock shares on March 13, 2026.

Is Laura D. Brown’s HELIOS TECHNOLOGIES (HLIO) Form 4 transaction routine compensation?

The Form 4 describes restricted stock units that each convert into one share of Common Stock upon vesting, with no exercise price. This structure is consistent with routine equity compensation for directors receiving stock-based awards.